4//SEC Filing
Atkisson Erik 4
Accession 0001567619-23-001473
CIK 0001305253other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 9:15 PM ET
Size
5.5 KB
Accession
0001567619-23-001473
Insider Transaction Report
Form 4
Atkisson Erik
GC & Chief Compliance Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-01-26+26,750→ 26,750 totalExercise: $1.37Exp: 2033-01-26→ Common Stock (26,750 underlying)
Footnotes (1)
- [F1]The option vests as to 50% on the first anniversary of the January 26, 2023 grant date, and as to the remaining 50% on June 26, 2024, subject to the Reporting Person's continuous service as of each such date. The option vests in full upon a change in control of the Issuer.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001885915
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 9:15 PM ET
- Size
- 5.5 KB